NIH Study Looks At Long-Acting Asthma Drugs For Children
Wall Street Journal
The other option is to use a leukotriene-receptor agonist like Merck's Singulair. Until now there's been little data to guide doctors on which option might

and more »

Merck Asthma Treatment Shows Positive Results In Study >MRK
Wall Street Journal
drug candidates after the Whitehouse Station, NJ, pharmaceutical giant recently emerged from patent battles leaving its best-selling Singulair free of

and more »

MiamiHerald.com
Medco's Snow: More Original Research to Aid Care, Cut Costs
Wall Street Journal (blog)
He said he took an asthma drug, Merck's Singulair, for two years before learning through a genetic test that he couldn't metabolize it.
New Clients and Drug Prices Lift Medco 4Q ProfitNew York Times

all 407 news articles »

Washington Post
Smooth Schering Integration in Merck's 4Q
Toronto Star
Merck's drugs posted strong gains in the quarter. The company's top-selling drug Singulair for respiratory disease increased 12% year over year,
Merck Revenues Rise Smartly, but It's Still Planning More LayoffsDailyFinance
Merck & Co posts strong results, unveils 17500 job cut plansPharma Times
Merck: Mergers and Layoffs and Pipelines, Oh My!PharmExec.com
New York Times (blog) -Wall Street Journal
all 382 news articles »

US Patent Office Tentatively Rejects Plavix Claims
Wall Street Journal
(MRK)--the PTO tentatively rejected claims in Merck's patent for asthma drug Singulair during a re-exam, but then upheld the claims in December and

and more »

AAAAI: Lack of Controller Meds Linked to Asthma Deaths
MedPage Today
In six cases, the patients had histories of illicit drug use: three had used marijuana, two each had used cocaine and heroin, and one each had used Ecstasy

and more »

Merck Oral Allergy Immunotherapy Treatment Reduces Symptoms
Wall Street Journal
drug candidates after the pharmaceutical giant recently emerged from patent battles leaving its best-selling Singulair free of generic competition until

and more »

New Drugs for Allergies
EmpowHer (blog)
Montelukast (brand name Singulair) is already approved for allergies as well as asthma. This is a once-a-day pill. A recent medical article reports that it

Time to Take Your Medicine, America
Atlantic Online (blog)
Increasingly, insurers and employers are cutting or eliminating drug co-pays for patients with chronic conditions; the thinking is that patients will take

and more »

Dr. Donohue: Steroid inhalers can decrease asthma attacks
Alexandria Town Talk
Singulair, Accolate and Zileuton are effective asthma drugs, and they are not steroids. I haven't mentioned all the possible asthma medicines.

and more »

Merck Announces Fourth-Quarter and Full-Year 2009 Financial Results
WebWire (press release)
Worldwide sales of SINGULAIR (montelukast sodium), a once-a-day oral medicine indicated for the chronic treatment of asthma and the relief of symptoms of

and more »

Queensbury woman testifies before FDA panel
Glens Falls Post-Star
Depression had been added as a possible side effect of the drug in April 2007, but there was no public notification of the finding, said state Sen.

New Drugs for Allergies
EmpowHer (blog)
Side effects include injection site reactions, viral infections, upper respiratory tract infection, sinusitis, headache, sore throat, and rare cases of

Inhalers can help with attack
Martinsburg Journal
The side effects of steroids are minimized when they're delivered by an inhaler. I checked five steroid inhalers for mention of weight gain and couldn't

and more »

Time to Take Your Medicine, America
Atlantic Online (blog)
about people who discontinue their Singulair or calcium channel blockers because of fairly mild side effects, or just because they can't be bothered.

and more »

Washington Post
Merck & Co., Inc. Q4 2009 Earnings Call Transcript
Seeking Alpha (blog)
Well, first -- in the first quarter we expect a pull back in the Cozaar/Hyzaar trade inventory levels to below normal levels as the patent expires data
Highlights From MRK's Q4 Conference Call: Schering-Plough Merger Continues StreetInsider.com (subscription)
Merck revenue beats, confident on financial goalsReuters
Merck Announces Fourth-Quarter and Full-Year 2009 Financial ResultsWebWire (press release)

all 382 news articles »

Medco's Snow: More Original Research to Aid Care, Cut Costs
Wall Street Journal (blog)
He said he took an asthma drug, Merck's Singulair, for two years before learning through a genetic test that he couldn't metabolize it.
New clients and drug prices lift Medco 4Q profitBusinessWeek

all 407 news articles »

Washington Post
Smooth Schering Integration in Merck's 4Q
Toronto Star
The company's top-selling drug Singulair for respiratory disease increased 12% year over year, which slightly exceeded our expectations.
Merck Revenues Rise Smartly, but It's Still Planning More LayoffsDailyFinance
Merck & Co posts strong results, unveils 17500 job cut plansPharma Times
Merck & Co net jumps to $6.5 billion in Q4pharmabiz.com
BloggingStocks (blog) -Seeking Alpha (blog) -The Associated Press
all 382 news articles »

Queensbury woman testifies before FDA panel
Glens Falls Post-Star
Miller's 15-year-old son, Cody, committed suicide in August 2007, 17 days after being on the allergy medication Singulair. Depression had been added as a

US Patent Office Tentatively Rejects Plavix Claims
Wall Street Journal
(MRK)--the PTO tentatively rejected claims in Merck's patent for asthma drug Singulair during a re-exam, but then upheld the claims in December and

and more »

NIH Study Looks At Long-Acting Asthma Drugs For Children
Wall Street Journal
The other option is to use a leukotriene-receptor agonist like Merck's Singulair. Until now there's been little data to guide doctors on which option might

and more »

Merck Asthma Treatment Shows Positive Results In Study >MRK
Wall Street Journal
NJ, pharmaceutical giant recently emerged from patent battles leaving its best-selling Singulair free of generic competition until 2012.

and more »

Merck Oral Allergy Immunotherapy Treatment Reduces Symptoms
Wall Street Journal
after the pharmaceutical giant recently emerged from patent battles leaving its best-selling Singulair free of generic competition until 2012.

and more »

New Drugs for Allergies
EmpowHer (blog)
Montelukast (brand name Singulair) is already approved for allergies as well as asthma. This is a once-a-day pill. A recent medical article reports that it

AAAAI: Test May Identify Asthma Patients Unresponsive to Steroids
MedPage Today
(Xolair) or montelukast (Singulair), Goleva suggested in a featured poster presentation at the American Academy of Allergy, Asthma & Immunology meeting.

Washington Post
Merck & Co., Inc. Q4 2009 Earnings Call Transcript
Seeking Alpha (blog)
For JANUVIA, ISENTRESS and SINGULAIR, for example, we made strategic investments in the fourth quarter to grow these brands. We also invested in our new
Highlights From MRK's Q4 Conference Call: Schering-Plough Merger Continues StreetInsider.com (subscription)
Merck revenue beats, confident on financial goalsReuters
Schering-Plough Deal Boosts Merck's ProfitWall Street Journal

all 382 news articles »

New clients and drug prices lift Medco 4Q profit
The Associated Press
Costs from new clients are higher at the beginning of the year, he said, and Medco is expecting a smaller contribution from new generic drugs in the first

7 Drug Stocks to Buy Now
Kiplinger.com
Granted, the brand-name drug companies are barreling toward a “patent cliff” as more than $130 billion in products go generic over the next few years.

New clients and drug prices lift Medco 4Q profit
BusinessWeek
Costs from new clients are higher at the beginning of the year, he said, and Medco is expecting a smaller contribution from new generic drugs in the first

and more »